These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11300592)

  • 1. Efficacy of a single oral dose of isorsorbide 5-mononitrate in normal dogs and in dogs with congestive heart failure.
    Adin DB; Kittleson MD; Hornof WJ; Kass PH
    J Vet Intern Med; 2001; 15(2):105-11. PubMed ID: 11300592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
    Kogi K; Satoh T
    Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo.
    Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G
    Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
    Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
    Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.
    Holman ND; Hoekstra OS; Groeneveld AB; Schneider AJ; de Voogt WG; van der Meer J
    Eur J Clin Pharmacol; 1994; 47(4):325-30. PubMed ID: 7875183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction of the direct renin inhibitor aliskiren with furosemide and extended-release isosorbide-5-mononitrate in healthy subjects.
    Vaidyanathan S; Bartlett M; Dieterich HA; Yeh CM; Antunes A; Howard D; Dole WP
    Cardiovasc Ther; 2008; 26(4):238-46. PubMed ID: 19035874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of three organic nitrates in Chinese healthy male volunteers.
    Chen J; Jiang XG; Cai L; Lu W; Gao KP; Shi ZQ; Zhang QZ
    Arzneimittelforschung; 2004; 54(4):203-6. PubMed ID: 15146932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption and excretion of isosorbide dinitrate and isosorbide-2-mononitrate in dogs.
    Cayen MN; Hicks D; Karounis J; Dvornik D
    J Pharm Pharmacol; 1983 May; 35(5):312-6. PubMed ID: 6134800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of isosorbide 5-mononitrate on cardiovascular function. (I). Effects on the left ventricular system].
    Kogi K; Saito T
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):335-42. PubMed ID: 4029805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.
    Müller S; Laber U; Müllenheim J; Meyer W; Kojda G
    J Am Coll Cardiol; 2003 Jun; 41(11):1994-2000. PubMed ID: 12798571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracoronary isosorbide mononitrate versus placebo. A double-blind study with quantitative coronary angiography].
    Vieira Botelho R; Feres F; São Thiago LE; Abud R; Carneiro JK; Pinto I; Rego Sousa AG; Rego Sousa JE
    Arq Bras Cardiol; 1995 Oct; 65(4):313-5. PubMed ID: 8728803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.
    Stokes GS; Bune AJ; Huon N; Barin ES
    Hypertension; 2005 Mar; 45(3):380-4. PubMed ID: 15699445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.
    McClennen W; Hornestam B; Jonsson UE; Held P
    Br J Clin Pharmacol; 1995 Jun; 39(6):704-8. PubMed ID: 7654494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction.
    Jackson G; Keltai M; Csanady M; Edes I; Bellamy GR; Widimsky P; Lisa L; Gillies H
    J Sex Med; 2005 May; 2(3):407-14. PubMed ID: 16422873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a sustained-release form of isosorbide dinitrate on left atrial pressure in dogs with experimentally induced mitral valve regurgitation.
    Yamamoto Y; Suzuki S; Hamabe L; Aytemiz D; Huai-Che H; Kim S; Yoshiyuki R; Fukayama T; Fukushima R; Tanaka R
    J Vet Intern Med; 2013; 27(6):1421-6. PubMed ID: 24010635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate.
    Jugdutt BI; Khan MI; Jugdutt SJ; Blinston GE
    Circulation; 1995 Aug; 92(4):926-34. PubMed ID: 7641376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats.
    Van de Casteele M; Van Roey G; Nevens F; Fevery J
    Hepatology; 1996 Dec; 24(6):1492-6. PubMed ID: 8938186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.